Circe BioTech is a disruptive group of transformative green tech businesses anchored in Austria, with a global reach. Their portfolio covers a wide range of sustainable solutions including Single Cell Protein, Gas Fermentation, Biodegradable Plastics, PHA, PHB, Composting, and Novel marine sourced enzymes. The company was established in 2019 with a focus on leveraging innovative technologies to address global environmental challenges. While the specific industries they operate in are not disclosed, Circe BioTech presents a promising opportunity for venture capitalists seeking to support sustainable and impactful ventures in the green tech sector. With their headquarters in Austria, Circe BioTech is poised to make tangible contributions to the global green revolution. As of now, details about the last investment and the involved investors are not available, but the vision and diversity of their offerings make Circe BioTech an intriguing entity for potential investors seeking to support cutting-edge sustainable solutions.
There is no investment information